(Q35262086)

7 August 2017

0 references

Neurochemical and neuropharmacological aspects of depression (English)

1 reference

7 August 2017

Neurochemical and Neuropharmacological Aspects of Depression (English)

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60039-2

10 October 2022

author name string

B. E. Leonard

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1354

9 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1354

9 March 2022

publication date

1 January 1975

1 reference

International Review of Neurobiology

7 August 2017

published in

1 reference

7 August 2017

volume

18

1 reference

7 August 2017

page(s)

357-387

1 reference

3',5' cyclic adenosine monophosphate in depression and mania.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Possibilities for drug development based on the cyclic AMP system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Uric-acid metabolism in manic-depressive illness and during lithium therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Biogenic Amines and Behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Urinary steroids in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Cyclic adenosine monophosphate phosphodiesterase in brain: effect on anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Assessing Clinical Characteristics of the Manic State

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Physiologic and Pharmacologic Considerations of Biogenic Amines in the Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Psychological stress and endocrine functions; blood levels of adrenocortical and thyroid hormones in acutely disturbed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

1 reference

7 January 2021

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Cerebrospinal fluid 5-hydroxyindoles and behavior after l-tryptophan and pyridoxine administration to psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Amitriptyline in man: Decreased formation of central 5-hydroxyindoleacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Urinary excretion of cyclic AMP and manic-depressive psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Norepinephrine in depressive reactions. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

L-dopa in depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Monoamine precursors in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Sequential comparison of L-tryptophan with E.C.T. in severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Quantitative studies of norepinephrine uptake by synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Indoleamines and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

CHANGES IN 5-HYDROXYTRYPTOPHAN METABOLISM IN DEPRESSION

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Mineral metabolism in mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Tryptophan in the treatment of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The effect of lithium on cerebral monoamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effect of phenmetrazine, aminorex and (±) p‐chloramphetamine on the motor activity and turnover rate of brain catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Further studies on iproniazid phosphate; isonicotinil-isopropyl-hydrazine phosphate marsilid

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The combined use of α-methyltyrosine and threo-dihydroxyphenylserine—selective reduction of dopamine levels in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Tryptophan Pyrrolase—A Biochemical Factor in Depressive Illness?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Efficacy of Tranquilizing and Antidepressant Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effects of Drugs on Uptake of Isotopic Norepinephrine by Cat Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effect of L-Tryptophan on Brain Serotonin Metabolism in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Differential Catechol-O-Methyltransferase Activity in Unipolar and Bipolar Affective Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Exercise and urinary excretion of cyclic A.M.P.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Metabolism of Tryptophan in Depressive Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Further structure-activity studies on the lowering of brain 5-hydroxyindoles by 4-chloroamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Morphological and Functional Aspects of Central Monoamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Psychotic reactions induced by corticotropin (ACTH) cortisone.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Changes in brain monoamine concentrations during the oestrous cycle in the mouse: possible pharmacological implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Evidence that the CCENTRAL ACTION OF (+)-amphetamine is mediated via catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Depression induced by Rauwolfia compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The action of reserpine in imipramine-resistant depressive patients. Clinical and biochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Uptake mechanisms for neurotransmitter amines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Homovanillic acid levels in rat striatum during the oestrous cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Differential effects of amphetamine, fenfluramine and norfenfluramine stereoisomers on the increase of striatum homovanillic acid in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Psychiatric reactions to oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

An in vitro model for the study of psychotropic drugs and as a criterion of antidepressant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Management of endogenous depressions using psychopharmacologic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Prognostic Factors in Treatment of Depressive States with Imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Drug therapoy of clinical depressions--current status and implications for research on neuropharmacology of the affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTP

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The intravenous probenecid test: a possible aid in evaluation of the serotonin hypothesis on the pathogenesis of depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The treatment of depressive states with G 22355 (imipramine hydrochloride).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The tricyclic antidepressants—Inhibition of norepinephrine uptake as related to potentiation of norepinephrine and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effect of desmethylimipramine, iprindole and DL-erythro-alpha-(3,4-dichlorophenyl)-beta-(t-butyl amino) propanol HC1 on the metabolism of amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Catecholamine Metabolism, Depressive Illness, and Drug Response

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Some factors in the regulation of central serotonergic synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Rubidium: a potential modifier of affect and behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Comparative effects of p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Amine precursors, amines, and false neurotransmitters in depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Clinical and pharmacological investigations of the psychobiology of the affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The classification of the functional psychoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The picture puzzle of the postpartum psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Urinary adenosine 3',5'-monophosphate excretion in affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Urinary adenosine 3',5'-monophosphate in the switch process from depression to mania

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Urinary cyclic AMP in periodic catatonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

NOREPINEPHRINE: A POSSIBLE EXCITATORY NEUROHORMONE OF THE REWARD SYSTEM.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Stereotyped activities produced by amphetamine in several animal species and man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Iprindole and Imipramine in Non-Psychotic Depressed Out-Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Accumulation of tritiated 5-hydroxytryptamine in brain slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Measuring the pharmacological action of imipramine in the treatment of depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Monoamine Oxidases: the Present Status

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Description and classification of depressive disorders. Contributions for the definition of the therapy-resistance and of therapy resistant depressions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The effects of psychoactive drugs on norepinephrine-3H metabolism in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The catecholamine hypothesis of affective disorders: a review of supporting evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Neuropharmacology of the affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Biogenic amines and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The effects of lithium on norepinephrine turnover and metabolism: basic and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Normetanephrine Excretion and Affective State in Depressed Patients Treated with Imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effects of tricyclic antidepressants on the uptake and metabolism of intracisternally administered norepinephrine-H3 in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The effects of lithium salts on the turnover and metabolism of norepinephrine in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

3-Methoxy-4-hydroxyphenylglycol in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Serum dopamine-?-hydroxylase (D?H) activity and affective states

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Nervous and mental disorders in Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Brain Norepinephrine: Enhanced Turnover after Rubidium Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Humoral changes in manic-depressive psychosis with particular reference to the excretion of catechol amines in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Further evidence for the heterogeneous storage of noradrenaline in central noradrenergic terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

The acute effects of oestrogen and progesterone on the monoamine levels of the brain of ovariectomised rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Neuropsychiatric aspects of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Effects of phenothiazine tranquilizers on the cyclic 3',5'-adenosine monophosphate system of rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-Chloro-N-Methylamphetamine)

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Cerebral monoamines and depression. An investigation with the Probenecid technique

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

5-hydroxyindoleacetic cid in spinal fluid: relative contribution from brain and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Oral contraceptives and psychiatric disturbance: evidence from research

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Oral contraceptives, pyridoxine, and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Kinetics of serotonin accumulation into synaptosomes of rat brain--effects of amphetamine and chloroamphetamines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Brain 3 H-catechol synthesis and the vaginal estrous cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2960039-2

7 January 2021

Pharmacological Reviews

78

18

775

Glowinski

1966

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60039-2

9 March 2022

Pharmacological Reviews

79

18

1201

Glowinski

1966

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60039-2

9 March 2022

Pharmacological Reviews

158

24

331

Sandier

1972

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60039-2

9 March 2022

Identifiers

0 references

1 reference